Ameriprise
CNCE

Ameriprise’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Ameriprise’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-25,191
Closed -$318K – 3919
2020
Q4 		$318K Sell
25,191
-11,408
-31% -$130K ﹤0.01% 3488
2020
Q3 		$359K Sell
36,599
-2,027
-5% -$20K ﹤0.01% 3365
2020
Q2 		$384K Sell
38,626
-385
-1% -$3.69K ﹤0.01% 3284
2020
Q1 		$345K Buy
39,011
+1,936
+5% +$19.1K ﹤0.01% 3258
2019
Q4 		$342K Buy
+37,075
New +$263K ﹤0.01% 3446
2014
Q4 		– Sell
-66,758
Closed -$842K – 4557
2014
Q3 		$842K Buy
+66,758
New +$647K ﹤0.01% 2875

Other funds holding CNCE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise's CNCE Position: Q1 2021 in Review

Ameriprise sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2021, closing a stake of 25,191 shares — an estimated $318K sold.

Ameriprise first reported a position in CNCE in Q3 2014 and held it in 6 quarters. The position peaked at $842K in Q3 2014. 91 funds tracked by Wall St. Rank hold CNCE as of Q1 2021.

  • Ameriprise reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
  • Ameriprise sold 25,191 Concert Pharmaceuticals, Inc. shares in Q1 2021, an estimated $318K.
  • Ameriprise first reported a position in Concert Pharmaceuticals, Inc. in Q3 2014 and held it in 6 quarters.
  • Ameriprise's Concert Pharmaceuticals, Inc. position peaked at $842K in Q3 2014.
  • 91 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2021.

Based on Ameriprise's 13F filing for Q1 2021, filed 17 May 2021.